Moderna’s COVID-19 mRNA vaccine trial was one of the most diverse clinical trials in history. LaQuinta Jernigan, Executive Vice President for the Americas at mdgroup …

The drug development landscape for vitiligo is sparse despite its social impact on individuals irrespective of race, ethnicity, or gender. Sometimes dubbed a “cosmetic condition,” …

Wearables have the potential to transform healthcare. They can help to inform timely, data-driven interventions. But validating each new digital measure is time-consuming, intensive, and …

This past year has seen life sciences companies settle into new operating models and digital ways of working, many of whom have come to realise …

The COVID-19 pandemic created a public health emergency that has had a profound impact on all aspects of the clinical trial industry. Quarantine requirements and …

By empowering researchers to detect data quality issues in real-time, Risk-Based Quality Management (RBQM) and Risk-Based Monitoring (RBM) have proven their value during the race …

The Malaysian government has continuously strived to improve and expand its clinical research ecosystem for the past ten years. The primary goal is to provide …

Classical drug development is undoubtedly indication- and product-driven. Simply put, a preclinically developed substance is optimised for clinical application in an appropriate galenic preparation and, …

Pharma Starts its Psychedelic Journey Steffanie Wilson at The Emmes Company affirms that both public and medical opinion is changing quickly and substances that were …

While clinical trials have become lengthy and very costly with low success rates, the application of innovative artificial intelligence (AI)- based approaches has been recognised …